In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
In this reminiscence about his friend, the founder of POZ shares personal insights on the late author and activist.
Researchers study older people living with the virus.
Young long-term survivors continue to face challenges.
In remembrance of Larry Kramer, who died in May at age 84, we dedicated our September magazine cover to him.
Longtime HIV advocates share their insights on COVID-19, social justice and living through two pandemics.
The legendary AIDS activist was also an accomplished author.
Supreme Court decisions and a Trump pronouncement on health care affect HIV efforts
These dates represent milestones in the HIV epidemic.
Sewing to remember AIDS losses and to protect against COVID-19
These masks keep HIV messaging in everyone’s face while raising funds for a good cause.
POZ editor-in-chief Oriol R. Gutierrez Jr. shares his experiences testing antibody positive for COVID-19.
The nonprofit organization One Heartland shares how COVID-19 threatens the survival of the summer camp it created in response to AIDS.
Activists and celebrities remember the longtime HIV advocate on social media.
Abnormal body fat distribution is still a concern for many people living with HIV.
Ask POZ is an ongoing section on POZ.com dedicated to answering general wellness questions.
Cabotegravir injections given every eight weeks as PrEP are even more effective than daily Truvada.
The immune modulator Pomalyst led to remission in two thirds of people with AIDS-related Kaposi sarcoma.
Fatty liver disease is tied to risk of metabolic problems in people with HIV.
It’s tied to worse health outcomes in people with HIV.
The 2-1-1 HIV prevention regimen offers an option for those who don’t want to take daily pills.
A mid-stage trial shows islatravir plus Pifeltro shows promise as two-drug HIV regimen.
A man with HIV is in long-term viral remission after intensified treatment.
A recent study links simplified HIV treatment with a greater risk of inflammation.
As president and CEO of AIDS United, Jesse Milan Jr. works tirelessly to end the HIV epidemic in the United States.
Read the digital edition!